Company Information


Shanghai, China


Wang Qunbin


Fosun International Limited is a multinational company that has been listed on the main board of the Hong Kong Stock Exchange (00656:HK) since 2007. Founded in 1992, Fosun's total assets exceed RMB500 billion (c.US$75 billion). With its roots in China, and through technology and innovation, Fosun's mission is to create customer-to-maker (C2M) ecosystems in health, happiness and wealth, providing high-quality products and services for families around the world.

Arix has a strategic partnership with Fosun to invest in and create new companies focused on the development of innovative clinical therapies across a broad range of therapeutic areas, with a particular emphasis on the Chinese market which is the second largest pharmaceutical market after the US. The relationship with Fosun will provide a unique "footprint" and network in the region via sharing potential investment opportunities in China; Arix provides Fosun access to its portfolio companies and potential opportunity to promote its services as exclusive distribution partner in China.

Our Partners

Learn more about our other partners.